Tuesday, October 25, 2011

Dr. Ed Kaye on ALS and Incentive Prizes: The Extended Interview

As part of our continuing series featuring interviews with some of the leading players in the field of ALS research, drug development, and treatment, Prize4Life spoke with Dr. Ed Kaye, currently the Chief Medical Officer at AVI BioPharma and the former Group Vice President and Therapeutic Head for Lysosomal Storage Disorders and Neurodegenerative Diseases at Genzyme Corporation. Dr. Kaye serves on Prize4Life's Scientific Advisory Board. In this video, he shares his thoughts on the recent $1M ALS Biomarker Prize award, the importance of private funding to complement public funding of ALS research, and the potential of the incentive prize model in biomedical research.

You can watch all of the extended interviews by subscribing to our YouTube channel here. You can also view the original video these interviews were collected for, 'Driving Breakthroughs in ALS Research: Prize4Life and the $1M ALS Biomarker Prize,' below.


  1. Dr. Ed Kaye, the Chief Medical Officer at AVI BioPharma is good speaker

  2. Thanks a lot for adding this valuable information here.I have been looking forward for content like this.I shall say at the end that the writing skills of the writer are extra ordinary...
    Logo Design

  3. This is a must read information and very valuable in respect of health as it truly said "health is wealth".

    health care solutions

  4. really a great article, provide a lot of information about the cell therapy.

  5. Thank you for a great weblog submit. I really enjoyed reading it. This website has got some really useful info on it! I was looking for this. It was excellent and very informative. PLEASE keep it up!